$12M in Endeavor Awards Fuels Cross-Disciplinary Cancer Research…

Event summary

$12 million awarded to four multi-institutional teams across five countries.
Endeavor Awards portfolio now totals 15 grants, $50 million since 2021.
Grants support research on liver metastases, immunotherapy resistance, tumor microenvironment, and transcription factors.
Teams leverage structural biophysics, spatial transcriptomics, and generative AI.
Three-year grants provide $3 million each for interdisciplinary collaboration.

The big picture

The Mark Foundation's $12 million investment underscores the growing importance of interdisciplinary collaboration in cancer research. As traditional funding models face challenges, the foundation's agile, international approach aims to accelerate breakthroughs in treatment-resistant cancers. With over $50 million committed to team science since 2021, the Endeavor Awards program is positioning itself as a key driver in the fight against aggressive cancer types.

What we're watching

Collaboration Dynamics: How The Mark Foundation's international funding model will sustain cross-disciplinary research amid global funding uncertainties.
Clinical Translation: The pace at which these high-risk, high-reward projects advance from lab discoveries to clinical trials.
Technological Integration: Whether AI-enabled structural biology and other cutting-edge tools can overcome traditional research boundaries.